AOXING PHARMACEUTICAL COMPANY | 0,148 Euro | -0,015 -9,20 % | |
| WKN: A1CUXU ISIN: US03740A1060 Ticker-Symbol: 5CA1 | Frankfurt | 17.05.13 | 08:00 Uhr |
Branche PharmaAktienmarkt ASIEN |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 15.05. | Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year | 37 | PR Newswire | |
| JERSEY CITY, N.J., May 15, 2013 /PRNewswire/ --Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing... Mehr lesen zu: Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year | ||||
| 15.05. | AOXING PHARMACEUTICAL COMPANY, INC. - 10-Q, Quaterly Report | - | SEC Filings | |
| 02.05. | AOXING PHARMACEUTICAL COMPANY, INC. - 8-K, Current Report | - | SEC Filings | |
| 15.02. | Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Second Quarter Of 2013 Fiscal Year | 47 | PR Newswire | |
| JERSEY CITY, N.J., Feb.15, 2013 /PRNewswire/ --Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development... Mehr lesen zu: Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Second Quarter Of 2013 Fiscal Year | ||||
| 14.02. | AOXING PHARMACEUTICAL COMPANY, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | |
| 28.01. | Aoxing Pharmaceutical Company, Inc. Announces Receipt Of Production License For Pholcodine | 11 | PR Newswire | |
| JERSEY CITY,N.J., Jan. 28, 2013 /PRNewswire/ -- Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing... Mehr lesen zu: Aoxing Pharmaceutical Company, Inc. Announces Receipt Of Production License For Pholcodine | ||||
| 14.11. | Aoxing Pharmaceutical Company, Inc. Announces Financial Results For First Quarter Of 2013 Fiscal Year | 30 | PR Newswire | |
| JERSEY CITY, N.J., Nov. 14, 2012 /PRNewswire/ --Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing... Mehr lesen zu: Aoxing Pharmaceutical Company, Inc. Announces Financial Results For First Quarter Of 2013 Fiscal Year | ||||
| 15.10. | Aoxing Pharmaceutical Company, Inc. Announced Financial Results For 2012 Fiscal Year | 43 | PR Newswire | |
| JERSEY CITY, N.J., Oct. 15, 2012 /PRNewswire/ -- Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development... Mehr lesen zu: Aoxing Pharmaceutical Company, Inc. Announced Financial Results For 2012 Fiscal Year | ||||
| 13.09. | Aoxing Pharmaceutical Company, Inc. Declines To Comment On Market Activity | 58 | PR Newswire | |
| JERSEY CITY, N.J., Sept. 13, 2012 /PRNewswire/ --Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN). In view of the unusual activity today in the market for the common stock of Aoxing Pharmaceutical... Mehr lesen zu: Aoxing Pharmaceutical Company, Inc. Declines To Comment On Market Activity | ||||
| 06.07. | Aoxing Pharmaceutical Company Announces Management Change | 47 | PR Newswire | |
| JERSEY CITY, N.J., July 6, 2012 /PRNewswire/ -- Aoxing Pharmaceutical Company, Inc. (NYSEAMEX: AXN), a specialty pharmaceutical company specializing in research, development, manufacturing and distribution... Mehr lesen zu: Aoxing Pharmaceutical Company Announces Management Change | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| CHINA NT PHARMA | 0,085 | +1,19 % | NT PHARMA (01011): FURTHER ANNOUNCEMENT IN RELATION TO THE ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2012 |
| TIANYIN PHARMACEUTICAL CO | 0,43 | -5,08 % | Tianyin Pharmaceutical's' Management Discusses F3Q2013 Results - Earnings Call Transcript |
| GALENA BIOPHARMA | 1,972 | +1,02 % | RXi Pharmaceuticals Corp - 8-K, Current Report |
| WUXI PHARMATECH | 15,715 | +1,39 % | Oppenheimer erhöht das Kursziel für Wuxi Pharma von $22 auf $25, Rating out... |
| CHINA PHARMA HOLDINGS | 0,101 | -15,13 % | China Pharma Slips To Loss In Q1 |
